Dr. Tarek Eldawy (Mohamed)

Claim this profile

Sacred Heart Hospital

Studies Breast Cancer
Studies Cancer
2 reported clinical trials
8 drugs studied

Area of expertise

1Breast Cancer
Tarek Eldawy (Mohamed) has run 1 trial for Breast Cancer. Some of their research focus areas include:
HER2 positive
ER positive
ER negative
2Cancer
Tarek Eldawy (Mohamed) has run 1 trial for Cancer. Some of their research focus areas include:
HER2 positive
ER positive
ER negative

Affiliated Hospitals

Image of trial facility.
Sacred Heart Hospital

Clinical Trials Tarek Eldawy (Mohamed) is currently running

Image of trial facility.

T-DM1 + Tucatinib

for Breast Cancer

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria

More about Tarek Eldawy (Mohamed)

Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Tarek Eldawy (Mohamed) has experience with
  • Trastuzumab Emtansine
  • Tucatinib
  • 3-Dimensional Conformal Radiation Therapy
  • Atezolizumab
  • Carboplatin
  • Cisplatin
Breakdown of trials Tarek Eldawy (Mohamed) has run
Breast Cancer
Cancer
Small Cell Lung Cancer
Lung Cancer
Small Cell Carcinoma

Other Doctors you might be interested in

Dany El-SayahSacred Heart Hospital
Erlyn C. SmithSacred Heart Hospital
Ranjith B. DissanayakeSacred Heart Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tarek Eldawy (Mohamed) specialize in?
Tarek Eldawy (Mohamed) focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Tarek Eldawy (Mohamed) currently recruiting for clinical trials?
Yes, Tarek Eldawy (Mohamed) is currently recruiting for 1 clinical trial in Pensacola Florida. If you're interested in participating, you should apply.
Are there any treatments that Tarek Eldawy (Mohamed) has studied deeply?
Yes, Tarek Eldawy (Mohamed) has studied treatments such as Trastuzumab Emtansine, Tucatinib, 3-Dimensional Conformal Radiation Therapy.
What is the best way to schedule an appointment with Tarek Eldawy (Mohamed)?
Apply for one of the trials that Tarek Eldawy (Mohamed) is conducting.
What is the office address of Tarek Eldawy (Mohamed)?
The office of Tarek Eldawy (Mohamed) is located at: Sacred Heart Hospital, Pensacola, Florida 32504 United States. This is the address for their practice at the Sacred Heart Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top